Systemic Therapy for Psoriasis and the Risk of Herpes Zoster
Author(s) -
Guy Shalom,
Devy Zisman,
Haim Bitterman,
Ilana HarmanBoehm,
Sari GreenbergDotan,
Jacob Dreiher,
Ilan Feldhamer,
Hadas Moser,
Ariel Hammerman,
Yoram Cohen,
Ar D. Cohen
Publication year - 2015
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2014.4956
Subject(s) - medicine , psoriasis , poisson regression , incidence (geometry) , relative risk , rate ratio , cohort , referral , comorbidity , dermatology , population , confidence interval , family medicine , physics , environmental health , optics
The risk for herpes zoster (HZ) in patients with psoriasis treated with biologic medications or other systemic treatments has been given little attention to date.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom